Breaking News

Recordati Acquires Pro Farma AG

Pro Farma’s main product Lacdigest will contribute to Recrodati’s growing presence in gastroenterology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Italian pharma company Recordati has acquired the Swiss pharma firm Pro Farma AG for approximately $16 million. With headquarters in Zug, Pro Farma says it expects 2016 revenues to be around $10 million. The company markets proprietary and in-licensed specialties in selected therapeutic areas, which include both prescription and OTC drugs. The main brands are Lacdigest (tilactase), Tretinac (isotretinoin) and Urocit (potassium citrate). In addition, the company offers distribution and promoti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters